<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65266">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01670838</url>
  </required_header>
  <id_info>
    <org_study_id>Kuopio UH</org_study_id>
    <nct_id>NCT01670838</nct_id>
  </id_info>
  <brief_title>Cardiopulmonary Complication in Aneurysmal Subarachnoid Haemorrhage Patients</brief_title>
  <acronym>SAHHEART</acronym>
  <official_title>Cardiopulmonary Complication in Aneurysmal Subarachnoid Haemorrhage Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kuopio University Hospital</source>
  <oversight_info>
    <authority>Finland: TUKIJA</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective cohort study investigating cardiac function and cardiac biomarkers in
      patients with acute Aneurysmal Subarachnoid Haemorrhage (aSAH). The aims of the study are to
      document the incidence of myocardial dysfunction,to find the predictive factors of
      myocardial dysfunction, describe heart rate variability and to assess the impact of all
      cardiac problems on morbidity and mortality.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Incidence of cardiac failure and the impact of cardiac problems on morbidity</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The aims of the study are:
to document the incidence of myocardial dysfunction
to find the predictive factors of myocardial dysfunction as determined by the severity aneurysmal bleeding (Hunt and Hess-grading, Glasgow coma score, Fisher scale) and demographic factors
to find  predictive factors for myocardial dysfunction as determined by laboratory findings, electrocardiography, and echocardiography
to describe heart rate variability
to assess the impact of all cardiac problems on morbidity</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Aneurysmal Subarachnoid Heamorrhage</condition>
  <condition>Nontraumatic Subarachnoid Haemorrhage</condition>
  <arm_group>
    <arm_group_label>subarachnoid haemorrhage</arm_group_label>
    <description>nontraumatic subarachnoid haemorrhage</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Study material consists of 200 consecutive aSAH-patients treated in Kuopio University
        Hospital and Turku University Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with nontraumatic subarachnoid haemorrhage

          -  Age &gt; 18 years

          -  Aneurysmal bleeding

        Exclusion Criteria:

          -  No consent

          -  Age &lt; 18 years

          -  Anticipated brain death &lt; 24 hours

          -  Otherwise moribund patient
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stepani Bendel, PhD, MD</last_name>
    <role>Study Director</role>
    <affiliation>Senior consultant, intensivist</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maarit Lång, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Senior consultant, intensivist</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maarit Lång, MD</last_name>
    <phone>+35817173430</phone>
    <email>maarit.lang@kuh.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stepani Bendel, PhD, MD</last_name>
    <phone>+35817173430</phone>
    <email>stepani.bendel@kuh.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <zip>PL 1777</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maarit Lång, MD</last_name>
      <phone>+35817173430</phone>
      <email>maarit.lang@kuh.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Riikka Takala, PhD, MD</last_name>
      <email>riikka.takala@tyks.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Inselspital Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jukka Takala, Professor</last_name>
    </contact>
    <investigator>
      <last_name>Jukka Takala, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 6, 2014</lastchanged_date>
  <firstreceived_date>August 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kuopio University Hospital</investigator_affiliation>
    <investigator_full_name>Maarit Lang</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>subarachnoid haemorrhage</keyword>
  <keyword>cardiopulmonary complications</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
